Financhill
Back

Carisma Therapeutics, Inc. Stock Predictions

Carisma Therapeutics, Inc. Stock Forecast

  • Is Carisma Therapeutics, Inc. Stock Undervalued?
    The current Carisma Therapeutics, Inc. [CARM] share price is $0.03. The Score for CARM is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • CARM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Carisma Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Carisma Therapeutics, Inc. Stock Rating

Data Unavailable

Carisma Therapeutics, Inc. Stock Price History

Is CARM stock going to rise?

  • The current trend is relatively stagnant and CARM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
carismatx.com

52-Week Data

52-Week High:
1.27
52-Week Low:
0.03

Prediction Charts

Market Cap:
1.4M
Price in USD:
0.03
Volume:
183.2K
Beta:
1.52

Technical Analysis

SMA50:
0.04
SMA100:
0.04
SMA200:
0.16
52-Wk Change:
-84.74%

Stock Predictions

  • Is Carisma Therapeutics, Inc. stock public?
    Yes, Carisma Therapeutics, Inc. is a publicly traded company.
  • What is the Carisma Therapeutics, Inc. stock quote today?
    The Carisma Therapeutics, Inc. stock price is 0.03 USD today.
  • How to buy Carisma Therapeutics, Inc. stock online?
    You can buy Carisma Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-16 0.04 0.04 0.04 0.04
Mar-17 0.04 0.04 0.04 0.04
Mar-18 0.04 0.04 0.04 0.04
Mar-19 0.04 0.04 0.04 0.04
Mar-20 0.04 0.04 0.04 0.03
Mar-23 0.03 0.03 0.04 0.03
Mar-24 0.03 0.04 0.04 0.03
Mar-25 0.04 0.03 0.04 0.03
Mar-26 0.03 0.03 0.04 0.03
Mar-27 0.03 0.03 0.04 0.03
Mar-30 0.03 0.03 0.04 0.03
Mar-31 0.04 0.03 0.04 0.03
Apr-1 0.03 0.03 0.04 0.03
Apr-2 0.03 0.03 0.04 0.03

Carisma Therapeutics, Inc. Earnings

Data Unavailable

Carisma Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.00 per share.

* Carisma Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.